Tolerability and Efficacy of Tremelimumab in Combination With Gefitinib in NSCLC Patients (GEFTREM)

Clinical Trial ID NCT02040064

PubWeight™ 8.98^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT02040064

Top papers